158 related articles for article (PubMed ID: 24061453)
1. Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification.
Arici A; Ozgur T; Ugras N; Yalcinkaya U
Indian J Cancer; 2013; 50(3):164-9. PubMed ID: 24061453
[TBL] [Abstract][Full Text] [Related]
2. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
4. Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.
Avallone G; Roccabianca P; Crippa L; Lepri E; Brunetti B; Bernardini C; Forni M; Olandese A; Sarli G
Vet Pathol; 2016 Jul; 53(4):773-80. PubMed ID: 26993784
[TBL] [Abstract][Full Text] [Related]
5. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall.
Schoolmeester JK; Sciallis AP; Greipp PT; Hodge JC; Dal Cin P; Keeney GL; Nucci MR
Int J Gynecol Pathol; 2015 Nov; 34(6):576-83. PubMed ID: 26444253
[TBL] [Abstract][Full Text] [Related]
6. Update on liposarcoma: a review for cytopathologists.
Dodd LG
Diagn Cytopathol; 2012 Dec; 40(12):1122-31. PubMed ID: 21932353
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.
Thway K; Flora R; Shah C; Olmos D; Fisher C
Am J Surg Pathol; 2012 Mar; 36(3):462-9. PubMed ID: 22301498
[TBL] [Abstract][Full Text] [Related]
8. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
10. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
11. Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings.
Ramírez-Bellver JL; López J; Macías E; Alegría-Landa V; Gimeno I; Pérez-Plaza A; Kutzner H; Requena L
J Cutan Pathol; 2017 Mar; 44(3):283-288. PubMed ID: 27778364
[TBL] [Abstract][Full Text] [Related]
12. Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma.
Segura-Sánchez J; González-Cámpora R; Pareja-Megia MJ; García-Escudero A; Galera-Ruiz H; López-Beltrán A
Anticancer Res; 2006; 26(6C):4937-42. PubMed ID: 17214366
[TBL] [Abstract][Full Text] [Related]
13. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
[TBL] [Abstract][Full Text] [Related]
14. p53 Expression in Canine Liposarcoma Correlates With Myxoid Variant and Higher Proliferative Activity.
Avallone G; Muscatello LV; Leoni A; Roccabianca P; Lepri E; Crippa L; Bacci B
Vet Pathol; 2020 Sep; 57(5):620-622. PubMed ID: 32744152
[TBL] [Abstract][Full Text] [Related]
15. Can HMGI-C be used as an aid with MDM2 and CDK4 to differentiate liposarcoma subtypes from their mimics?
Alshenawy H
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1073-81. PubMed ID: 23529275
[TBL] [Abstract][Full Text] [Related]
16. Liposarcomas: diagnostic pitfalls and new insights.
Dei Tos AP
Histopathology; 2014 Jan; 64(1):38-52. PubMed ID: 24118009
[TBL] [Abstract][Full Text] [Related]
17. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
18. Can MDM2 analytical tests performed on core needle biopsy be relied upon to diagnose well-differentiated liposarcoma?
Weaver J; Rao P; Goldblum JR; Joyce MJ; Turner SL; Lazar AJ; López-Terada D; Tubbs RR; Rubin BP
Mod Pathol; 2010 Oct; 23(10):1301-6. PubMed ID: 20495536
[TBL] [Abstract][Full Text] [Related]
19. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
20. Dedifferentiated liposarcoma with meningothelial-like whorls, metaplastic bone formation, and CDK4, MDM2, and p16 expression: a morphologic and immunohistochemical study.
Thway K; Robertson D; Thway Y; Fisher C
Am J Surg Pathol; 2011 Mar; 35(3):356-63. PubMed ID: 21317707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]